SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Zendesk, Inc. (ZEN) .
Criteria proven by this page:
- VALUE (90/100, Pass) — analyst target implies upside (+40.8%).
- Analyst consensus target $109.06 (+40.8% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 44/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
90/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ZEN
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio6.67
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.94
Book Value / Share$0.00
Revenue / Share$11.62
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$109.06 (+40.8%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$-0.43 |
$38.23M |
$-24.37M |
-63.7% |
| 2013 |
$-0.40 |
$72.05M |
$-22.57M |
-31.3% |
| 2014 |
$-1.26 |
$127.05M |
$-67.42M |
-53.1% |
| 2015 |
$-0.99 |
$208.77M |
$-84.05M |
-40.3% |
| 2016 |
$-1.11 |
$312M |
$-103.8M |
-33.3% |
| 2017 |
$-1.11 |
$430.49M |
$-110.64M |
-25.7% |
| 2018 |
$-1.24 |
$598.75M |
$-131.08M |
-21.9% |
| 2019 |
$-1.53 |
$816.42M |
$-169.65M |
-20.8% |
| 2020 |
$-1.89 |
$1.03B |
$-218.18M |
-21.2% |
| 2021 |
$-1.94 |
$1.34B |
$-223.64M |
-16.7% |
